Skip to main content
Log in

[14C]aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Twenty-eight patients with histologically confirmed cirrhosis were followed for up to 3.8 years after [14C]aminopyrine breath analysis. Survival rates were calculated by life-table method and outcome analyzed by log rank test. A normal breath test score was associated with a higher probability of survival than a low score, although the difference was not statistically significant. A normal serum albumin was a better predictor of outcome. Survival curves constructed according to the results of breath analysis and serum albumin differed in that the former appeared to predict early survival and the latter late survival. For this reason, data were reanalyzed by subjects' results for both tests. A normal breath test score and a normal serum albumin was associated with a significantly higher probability of survival than an abnormal result for either test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Galambos J: The cirrhoses.In Gastroenterology, 3rd ed. HL Bockus (ed) Philadelphia, WB Saunders, 1976, pp 401–403

    Google Scholar 

  2. Sherlock S: Diseases of the Liver and Biliary System, 5th ed. Oxford, Blackwell Scientific Publications, 1975, pp 455–456

    Google Scholar 

  3. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP: Portal hypertension, size of eosophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 79:1139–1144, 1980

    Google Scholar 

  4. Winkel P, Juhl E, Tygstrup N, and The Copenhagen Study Group for Liver Diseases: The prognostic value of clinical and laboratory data in patients with cirrhosis. Scand J Gastroenterol Suppl 7:181–187, 1970

    Google Scholar 

  5. Tygstrup N: The galactose elimination capacity in relation to clinical and laboratory findings in patients with cirrhosis. Acta Med Scand 175:291–300, 1964

    Google Scholar 

  6. Lindskov J: The quantitative liver function as measured by the galactose elimination capacity. II Prognostic value and changes during disease in patients with cirrhosis. Acta Med Scand 212:303–308, 1982

    Google Scholar 

  7. Hepner GW, Chopra IJ: Serum thyroid hormone levels in patients with liver disease. Arch Intern Med 139:1117–1120, 1979

    Google Scholar 

  8. Branch RA: Drugs as indicators of hepatic function. Hepatology 2:97–105, 1982

    Google Scholar 

  9. Saunders B, Wright N, Lewis KO: Predicting outcome of paracetamol poisoning by using [14C]aminopyrine breath test. Br Med J 280:279–280, 1980

    Google Scholar 

  10. Henry DA, Sharpe G, Chaplain S, Cartwright S, Kitchingman G, Bell GD, Langman MJS: The [14C]aminopyrine breath test a comparison of different forms of analysis. Br J Clin Pharmacol 8:539–545, 1979

    Google Scholar 

  11. Pauwels S, Geubel AP, Dive C, Beckers C: Breath14CO2 after intravenous administration of [14C]aminopyrine in liver diseases. Dig Dis Sci 27:49–56, 1982

    Google Scholar 

  12. Noordhoek J, Dees J, Savenije-Chapel EM, Wilson JHP: Output of14CO2 in breath after oral administration of [methyl-14C]aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: Its relationship to aminopyrine pharmacokinetics. Eur J Clin Pharmacol 13:223–229, 1978

    Google Scholar 

  13. Henry DA, MacDonald IA, Kitchingman G, Bell GD, Langman MJS: Cimetidine and ranitidine: Comparison of effects on hepatic drug metabolism. Br Med J 281:1–6, 1980

    Google Scholar 

  14. Hepner GW, Vesell ES: Quantitative assessment of hepatic function by breath analysis after oral administration of [14C]aminopyrine. Ann Intern Med 83:632–638, 1974

    Google Scholar 

  15. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1–39, 1977

    Google Scholar 

  16. Burnstein AV, Galambos JT: [14C]Aminopyrine breath test in chronic liver disease. Preliminary diagnostic implications. Dig Dis Sci 26:1078–1093, 1981

    Google Scholar 

  17. Morelli A, Narducci F, Pelli MA, Farroni F, Vedovelli A: The relationship between aminopyrine breath test and severity of liver disease in cirrhosis. Am J Gastroenterol 76:110–113, 1981

    Google Scholar 

  18. Galizzi J, Long RG, Billing BH, Sherlock S: Assessment of the [14C]aminopyrine breath test in liver disease. Gut 19:40–45, 1978

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henry, D.A., Kitchingman, G. & Langman, M.J.S. [14C]aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis. Digest Dis Sci 30, 813–818 (1985). https://doi.org/10.1007/BF01309509

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01309509

Keywords

Navigation